176 related articles for article (PubMed ID: 37598758)
1. The role of orexinergic system in the regulation of cataplexy.
Koyama Y
Peptides; 2023 Nov; 169():171080. PubMed ID: 37598758
[TBL] [Abstract][Full Text] [Related]
2. Neurobiology of cataplexy.
Seifinejad A; Vassalli A; Tafti M
Sleep Med Rev; 2021 Dec; 60():101546. PubMed ID: 34607185
[TBL] [Abstract][Full Text] [Related]
3. A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.
Uchida S; Soya S; Saito YC; Hirano A; Koga K; Tsuda M; Abe M; Sakimura K; Sakurai T
J Neurosci; 2021 Feb; 41(7):1582-1596. PubMed ID: 33372061
[TBL] [Abstract][Full Text] [Related]
4. Physiology of REM sleep, cataplexy, and sleep paralysis.
Hishikawa Y; Shimizu T
Adv Neurol; 1995; 67():245-71. PubMed ID: 8848973
[TBL] [Abstract][Full Text] [Related]
5. Narcolepsy in the older adult: epidemiology, diagnosis and management.
Chakravorty SS; Rye DB
Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
[TBL] [Abstract][Full Text] [Related]
6. Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.
Nishino S; Tafti M; Reid MS; Shelton J; Siegel JM; Dement WC; Mignot E
J Neurosci; 1995 Jul; 15(7 Pt 1):4806-14. PubMed ID: 7623112
[TBL] [Abstract][Full Text] [Related]
7. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
8. A circuit perspective on narcolepsy.
Adamantidis AR; Schmidt MH; Carter ME; Burdakov D; Peyron C; Scammell TE
Sleep; 2020 May; 43(5):. PubMed ID: 31919524
[TBL] [Abstract][Full Text] [Related]
9. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation.
Thakkar MM; Ramesh V; Cape EG; Winston S; Strecker RE; McCarley RW
Sleep Res Online; 1999; 2(4):112-20. PubMed ID: 11382892
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
11. Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans.
Nishino S; Riehl J; Hong J; Kwan M; Reid M; Mignot E
Neurosci Res; 2000 Dec; 38(4):437-46. PubMed ID: 11164570
[TBL] [Abstract][Full Text] [Related]
12. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future.
Tisdale RK; Yamanaka A; Kilduff TS
Sleep; 2021 Jun; 44(6):. PubMed ID: 33313880
[TBL] [Abstract][Full Text] [Related]
13. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
14. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
Dauvilliers Y; Jennum P; Plazzi G
Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
[TBL] [Abstract][Full Text] [Related]
15. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children.
Vassalli A; Dellepiane JM; Emmenegger Y; Jimenez S; Vandi S; Plazzi G; Franken P; Tafti M
Brain; 2013 May; 136(Pt 5):1592-608. PubMed ID: 23616586
[TBL] [Abstract][Full Text] [Related]
16. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823
[TBL] [Abstract][Full Text] [Related]
17. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice.
Thankachan S; Kaur S; Shiromani PJ
J Neurosci; 2009 Feb; 29(5):1580-5. PubMed ID: 19193905
[TBL] [Abstract][Full Text] [Related]
18. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice.
Kaushik MK; Aritake K; Cherasse Y; Imanishi A; Kanbayashi T; Urade Y; Yanagisawa M
Sleep; 2021 Aug; 44(8):. PubMed ID: 33609365
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsies, update in 2023.
Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for narcolepsy.
Abad VC; Guilleminault C
Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
